Why Drugs Get Pulled Off the Market. / Michelle Meadows.
by Meadows, Michelle; SIRS Publishing, Inc.
Material type:
Item type | Current location | Call number | Status | Date due |
---|---|---|---|---|
![]() |
High School - old - to delete | REF SIRS 2003 Hea2 (Browse shelf) | Available |
Browsing High School - old - to delete Shelves Close shelf browser
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
REF SIRS 2003 Hea16 Filling a Need. / | REF SIRS 2003 Hea18 Facing Prostate Cancer, But How?. / | REF SIRS 2003 Hea19 The Killer Bug. / | REF SIRS 2003 Hea2 Why Drugs Get Pulled Off the Market. / | REF SIRS 2003 Hea20 Mystery Maladies. / | REF SIRS 2003 Hea21 Social Problems of Children with ADHD. / | REF SIRS 2003 Hea21 The Mind Maze. / |
Articles Contained in SIRS Enduring Issues 2003.
Originally Published: Why Drugs Get Pulled Off the Market, Jan./Feb. 2002; pp. 11-17.
"When it comes to any drug, 'safe' means that the benefits of the drug outweigh the risks for the population the drug is intended to treat and for its intended use. 'Safe does not mean harmless...Every drug comes with risks, and our tolerance for risk is higher for drugs that treat serious and life-threatening illnesses. There is no question that cancer drugs can be highly toxic. But they also save lives.' " (FDA CONSUMER) This author discusses the evaluation process used by the Food and Drug Administration (FDA) to determine how "safe" a drug is and also analyzes how medications may be withdrawn from the market when adverse effects are found.
Records created from non-MARC resource.
There are no comments for this item.